Home » Topics » Regulatory

Regulatory
RSS

FDA approves Atripla, first once-daily single tablet regimen for HIV

July 13, 2006

FDA approves Emend for prevention of postoperative nausea and vomiting

July 12, 2006

Avandamet approved for initial treatment of type 2 diabetes

July 12, 2006

Revlimid approved for use in multiple myeloma

June 30, 2006

Sprycel approved for two new indications

June 29, 2006

Accelerated approval for Prezista in HIV combination therapy

June 26, 2006

European approval of Acomplia

June 23, 2006

Avastin approved for second-line use in metastatic colorectal cancer

June 21, 2006

Hycamtin approved for use with cisplatin in cervical cancer

June 19, 2006

Humira approved in Europe for ankylosing spondylitis

June 8, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...